Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSECN.L Regulatory News (SECN)

  • There is currently no data for SECN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Corporate Nominee Facility

8 Jun 2021 13:23

RNS Number : 2048B
SEC Newgate S.p.A.
08 June 2021
 

8 June 2021

SEC Newgate S.p.A.

("SEC Newgate", "the Company" or "the Group")

Closure of Corporate Nominee Facility (including the Porta Bare Trust)

SEC Newgate (AIM: SECN), the insight-driven global strategic communications group that works at the nexus of business, politics, communities, markets and media, announces that, in accordance with the Corporate Nominee Facility Terms and Conditions, and the scheme document dated 5 July 2019, which contained the full terms and conditions of the Scheme of Arrangement, the Corporate Nominee Facility (including the Porta Bare Trust) ("CNF") will close on 3 September 2021.

The CNF was established in September 2019, following the merger between SEC S.p.A. and Porta Communications Plc ("Porta"), to enable Porta shareholders, who so elected, to hold their SEC Newgate certificates of depositary interests ("CDIs") through a nominee facility. The CNF was established for a period of two years and is administered by Equiniti Financial Services Limited ("Equiniti").

Porta shareholders who did not respond with an election under the Scheme of Arrangement were defaulted into the Porta Bare Trust, with CDIs held by Equiniti as Corporate Nominee for Porta as Representative.

Equiniti has written to participants in the CNF (including those in the Porta Bare Trust) setting out the options available, being:

1. Transfer their shares to another provider who is capable of holding CREST Depository Interests (CDIs) on their behalf.

2. Sell their shares through the Equiniti Postal Share Dealing Service (normal charges apply).

3. If none of the above is selected, any remaining shares will be sold in accordance with Section 13.3 of the Corporate Nominee Facility Terms and Conditions and the net proceeds of any sale (converted to Sterling if required and after applicable dealing deductions), remitted to the participant by way of cheque drawn on a branch of a UK clearing bank.

Any election for Option 1 or 2 must be received by Equiniti by 20 August 2021 or Option 3 will be applied.

If a participant wishes to elect for Option 1 or 2, they should email CSNTransfers@equiniti.com quoting their Shareholder Reference and the relevant documentation (including the Equiniti Postal Share Dealing Service Terms and Conditions) will be issued to them.

For further information please contact:

SEC Newgate S.p.A.

 

Fiorenzo Tagliabue (Group CEO)

Tel: +39 335 6008858tagliabue@secrp.com

 

Emma Kane (Deputy Group CEO)

 

Tel: +44 (0)7876 338 339emma.kane@secnewgate.co.uk

Sergio Penna (Group CFO)

Tel: +39 338 8357936penna@secrp.com

 

Arden Partners (Nominated Adviser and Broker)

 

Tel: +44 (0)20 7614 5900

Richard Johnson 

 

 

Notes to Editors

· SEC Newgate is an award winning strategic communications firm, which ranks in the Top 30 groups in the world.   The Agency's   team consists of about 600 staff, working in 37 offices across five continents.

· SEC Newgate's focus is on achieving positive outcomes through communications, advocacy and research, helping clients clearly demonstrate their purpose, value, and impact locally, nationally and internationally.   

· Further information is available at the Group's website:    www.secnewgate.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBDGDLGDGDGBI
Date   Source Headline
3rd Mar 20225:30 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20227:00 amRNSTransaction in Own Shares
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20225:30 pmRNSSec Newgate SPA
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20221:44 pmRNSHolding(s) in Company
25th Feb 20227:52 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSHolding(s) in Company
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20229:30 amRNSTransaction in Own Shares
18th Feb 20227:30 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSCommencement of Buy-back
10th Feb 20221:00 pmRNSResult of General Meeting
10th Feb 20227:00 amRNSUpdate re Framework and Contribution Agreement
25th Jan 20227:00 amRNSNotice of General Meeting
19th Jan 202211:28 amRNSProposed AIM trading cancellation and financing
11th Nov 20217:00 amRNSTrading Update
26th Oct 20217:00 amRNSInaugural Global Thought Leadership Report
1st Sep 20217:01 amRNSNewington Vendor Consideration
1st Sep 20217:00 amRNSInterim Results
29th Jul 20217:00 amRNSAcquisition
28th Jun 20217:00 amRNSNew London Offices
10th Jun 20217:00 amRNSAnnual Report
8th Jun 20211:23 pmRNSUpdate re Corporate Nominee Facility
8th Jun 20211:12 pmRNSResult of AGM
28th May 20219:45 amRNSHolding(s) in Company
21st May 20218:14 amRNSIssue of Equity
21st May 20217:00 amRNSAudited Full Year Results
6th May 20217:00 amRNSYear End Trading Update and Notice of Results
22nd Mar 20217:00 amRNSExpansion in Central Eastern Europe
11th Mar 202112:33 pmRNSInvestor Presentation
24th Feb 20217:00 amRNSSEC Newgate UK wins prestigious industry award
2nd Feb 20217:01 amRNSBoard Changes
2nd Feb 20217:00 amRNSTrading Update
29th Jan 20217:00 amRNSDirector Dealing
26th Jan 20219:50 amRNSDirector Dealing
26th Jan 20219:00 amRNSEquity Research Initiation
19th Jan 202110:04 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSMerger and Rebranding of UK Agencies

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.